Aurora Cannabis Inc. (ACB:CNX) (ACBFF) wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., has been awarded a license to sell medicinal cannabis pursuant to the Marihuana for Medical Purposes Regulations (MMPR) from Health Canada. The sales license will allow Aurora to sell medicinal cannabis to patients across Canada.
Aurora's 55,200 square foot indoor production facility, located in Alberta, is capable of producing over 5,400 kg of medicinal-grade cannabis per year. Of all the publicly traded, fully licensed producers in Canada, Aurora has the second most licensed indoor production space and the largest purpose-built indoor production facility.
According to the company’s official site, Aurora Cannabis’ goal is to use the healing power of nature to help free those in need to enjoy lives of inspiration, activity, comfort, and wellbeing. "People seeking a holistic approach to health and wellness,” said Neil Belot, Chief Brand Officer of Aurora Cannabis, “who believe in medical cannabis and the healing power of nature, can now choose a culture and community minded Licensed Producer which truly understands their needs."
For both recreational and commercial use, the marijuana industry, is among the fastest growing industries in the world. Currently, all eyes in the marijuana sector are on Canada. The legalization of Marijuana looks certain with thelandslide victory of liberal party candidate and Prime Minister-elect Justin Trudeau’s, in the recent election.
Aurora Cannabis Facility set for Full Production Capacity in 2016
Receiving a sales license in the marijuana space is a major company milestone. However, Aurora Cannabis has made progress throughout 2015 in order to enter the Canadian medical marijuana space prior upon license approval. With a new comprehensive website set to launch in the coming days, pre-registration of patients will begin immediately and product deliveries are expected to commence before the end of the year. In June, the company completed its first harvest at its facility, the first marijuana production facility built in Alberta. The company anticipates the facility to be at its full production capacity by May 2016.
Aurora Cannabis is currently trading on the Canadian Securities Exchange under the trading symbol ACB, and the company’s wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the US Cannabis market. The company’s recent licensing achievement is not just big news in the Canadian marijuana market, but also vaults them into a leading position within the industry as they pursue the US market.
“The next phase in establishing the Aurora Standard,” said Terry Booth, CEO of Aurora Cannabis, “in producing and selling the highest quality cannabis now transitions into providing unparalleled customer service to all of our future patients."
For more information about Aurora Cannabis, visit www.auroramj.com.
Disclosure: In the purview of Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention the fact that Equities.com, Inc. may be compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker, broker dealer, investment advisor, analyst, investment banker or underwriter. All profiles are based on information that is available to the public. The information contained herein should not be considered to be all-inclusive and is not guaranteed by Equities.com to be free from misstatement or errors. Readers are reminded to do their own due diligence when researching any companies mentioned on this website.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer